BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19875392)

  • 1. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
    Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
    Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.
    Whiteman DC; Sadeghi S; Pandeya N; Smithers BM; Gotley DC; Bain CJ; Webb PM; Green AC;
    Gut; 2008 Feb; 57(2):173-80. PubMed ID: 17932103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
    Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC;
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms, investigations and management of patients with cancer of the oesophagus and gastro-oesophageal junction in Australia.
    Smithers BM; Fahey PP; Corish T; Gotley DC; Falk GL; Smith GS; Kiroff GK; Clouston AD; Watson DI; Whiteman DC
    Med J Aust; 2010 Nov; 193(10):572-7. PubMed ID: 21077812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohort.
    DE Jonge PJ; Wolters LM; Steyerberg EW; VAN Dekken H; Kusters JG; Kuipers EJ; Siersema PD
    Aliment Pharmacol Ther; 2007 Jul; 26(1):31-9. PubMed ID: 17555419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study.
    Steevens J; Schouten LJ; Goldbohm RA; van den Brandt PA
    Gut; 2010 Jan; 59(1):39-48. PubMed ID: 19828467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do low control response rates always affect the findings? Assessments of smoking and obesity in two Australian case-control studies of cancer.
    Pandeya N; Williams GM; Green AC; Webb PM; Whiteman DC
    Aust N Z J Public Health; 2009 Aug; 33(4):312-9. PubMed ID: 19689590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers.
    Harris RE; Beebe-Donk J; Schuller HM
    Oncol Rep; 2002; 9(4):693-5. PubMed ID: 12066194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
    Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
    BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
    Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary patterns and risk of oesophageal cancers: a population-based case-control study.
    Ibiebele TI; Hughes MC; Whiteman DC; Webb PM;
    Br J Nutr; 2012 Apr; 107(8):1207-16. PubMed ID: 21899799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis?
    Lagergren J
    Best Pract Res Clin Gastroenterol; 2006; 20(5):803-12. PubMed ID: 16997162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus.
    Pandeya N; Williams GM; Sadhegi S; Green AC; Webb PM; Whiteman DC
    Am J Epidemiol; 2008 Jul; 168(1):105-14. PubMed ID: 18483122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma.
    Beales IL; Vardi I; Dearman L
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):917-23. PubMed ID: 22569083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction.
    Olsen CM; Pandeya N; Green AC; Webb PM; Whiteman DC;
    Am J Epidemiol; 2011 Sep; 174(5):582-90. PubMed ID: 21719746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
    Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
    Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.
    Figueroa JD; Terry MB; Gammon MD; Vaughan TL; Risch HA; Zhang FF; Kleiner DE; Bennett WP; Howe CL; Dubrow R; Mayne ST; Fraumeni JF; Chow WH
    Cancer Causes Control; 2009 Apr; 20(3):361-8. PubMed ID: 18989634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
    Beales IL; Vardi I; Dearman L; Broughton T
    Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
    Liao LM; Vaughan TL; Corley DA; Cook MB; Casson AG; Kamangar F; Abnet CC; Risch HA; Giffen C; Freedman ND; Chow WH; Sadeghi S; Pandeya N; Whiteman DC; Murray LJ; Bernstein L; Gammon MD; Wu AH
    Gastroenterology; 2012 Mar; 142(3):442-452.e5; quiz e22-3. PubMed ID: 22108196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.